These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27922194)

  • 1. Pharmacodynamic response profiles of anxiolytic and sedative drugs.
    Chen X; Broeyer F; de Kam M; Baas J; Cohen A; van Gerven J
    Br J Clin Pharmacol; 2017 May; 83(5):1028-1038. PubMed ID: 27922194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.
    Baas JM; Mol N; Kenemans JL; Prinssen EP; Niklson I; Xia-Chen C; Broeyer F; van Gerven J
    Psychopharmacology (Berl); 2009 Jul; 205(1):73-84. PubMed ID: 19415242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
    Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
    Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anxiolytic treatment on potentiated startle during aversive image anticipation.
    Acheson DT; Stein MB; Paulus MP; Ravindran L; Simmons AN; Lohr JB; Risbrough VB
    Hum Psychopharmacol; 2012 Jul; 27(4):419-27. PubMed ID: 22782542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
    Riba J; Rodríguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
    Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.
    Hindmarch I; Dawson J; Stanley N
    Sleep; 2005 Feb; 28(2):187-93. PubMed ID: 16171242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
    Hindmarch I; Trick L; Ridout F
    Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.
    Nutt D; Mandel F; Baldinetti F
    J Psychopharmacol; 2009 Nov; 23(8):867-73. PubMed ID: 18635690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-clamp evidence of GABA
    Fernandes H; Batalha V; Braksator E; Hebeisen S; Bonifácio MJ; Vieira-Coelho MA; Soares-da-Silva P
    Pharmacol Rep; 2022 Oct; 74(5):956-968. PubMed ID: 36097257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment.
    Brunner LM; Maurer F; Weber K; Weigl J; Milenkovic VM; Rupprecht R; Nothdurfter C; Mühlberger A
    Psychopharmacology (Berl); 2022 Jul; 239(7):2233-2244. PubMed ID: 35278124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG.
    Blom MW; Bartel PR; de Sommers K; Van der Meyden CH; Becker PJ
    Fundam Clin Pharmacol; 1990; 4(6):653-61. PubMed ID: 1982881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cognitive effect of alprazolam in healthy volunteers].
    Drabant S; Tömlo J; Tóth M; Péterfai E; Klebovich I
    Acta Pharm Hung; 2006; 76(1):25-31. PubMed ID: 17094673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anxiolytic effect on the fear-potentiated startle is not due to a non-specific disruption.
    Joordens RJ; Hijzen TH; Olivier B
    Life Sci; 1998; 63(25):2227-32. PubMed ID: 9870708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alprazolam on the acoustic startle response in humans.
    Rodríguez-Fornells A; Riba J; Gironell A; Kulisevsky J; Barbanoj MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):280-5. PubMed ID: 10353431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZD6280, a novel partial γ-aminobutyric acid A receptor modulator, demonstrates a pharmacodynamically selective effect profile in healthy male volunteers.
    Chen X; Jacobs G; de Kam ML; Jaeger J; Lappalainen J; Maruff P; Smith MA; Cross AJ; Cohen A; van Gerven J
    J Clin Psychopharmacol; 2015 Feb; 35(1):22-33. PubMed ID: 25493397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
    Leicht G; Mulert C; Eser D; Sämann PG; Ertl M; Laenger A; Karch S; Pogarell O; Meindl T; Czisch M; Rupprecht R
    Biol Psychiatry; 2013 Feb; 73(4):337-44. PubMed ID: 23059050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valproate and pregabalin on human anxiety-like behaviour in a randomised controlled trial.
    Bach DR; Korn CW; Vunder J; Bantel A
    Transl Psychiatry; 2018 Aug; 8(1):157. PubMed ID: 30115911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.